Source:http://linkedlifedata.com/resource/pubmed/id/12808127
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
2003-6-30
|
| pubmed:abstractText |
To determine whether combined intravenous liposomal doxorubicin and radio-frequency (RF) ablation decreases tumor growth and increases endpoint survival over those with RF or liposomal doxorubicin alone in an animal tumor model.
|
| pubmed:grant | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jul
|
| pubmed:issn |
0033-8419
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
228
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
112-8
|
| pubmed:dateRevised |
2007-11-14
|
| pubmed:meshHeading |
pubmed-meshheading:12808127-Animals,
pubmed-meshheading:12808127-Antineoplastic Agents,
pubmed-meshheading:12808127-Catheter Ablation,
pubmed-meshheading:12808127-Combined Modality Therapy,
pubmed-meshheading:12808127-Doxorubicin,
pubmed-meshheading:12808127-Female,
pubmed-meshheading:12808127-Injections, Intravenous,
pubmed-meshheading:12808127-Mammary Neoplasms, Experimental,
pubmed-meshheading:12808127-Rats,
pubmed-meshheading:12808127-Rats, Inbred F344
|
| pubmed:year |
2003
|
| pubmed:articleTitle |
Percutaneous tumor ablation: reduced tumor growth with combined radio-frequency ablation and liposomal doxorubicin in a rat breast tumor model.
|
| pubmed:affiliation |
Minimally Invasive Tumor Therapy Laboratory, Department of Radiology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave, Boston, MA 02215, USA.
|
| pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|